Literature DB >> 30446950

Dopamine: Functions, Signaling, and Association with Neurological Diseases.

Marianne O Klein1, Daniella S Battagello1, Ariel R Cardoso1, David N Hauser2, Jackson C Bittencourt3,4, Ricardo G Correa5.   

Abstract

The dopaminergic system plays important roles in neuromodulation, such as motor control, motivation, reward, cognitive function, maternal, and reproductive behaviors. Dopamine is a neurotransmitter, synthesized in both central nervous system and the periphery, that exerts its actions upon binding to G protein-coupled receptors. Dopamine receptors are widely expressed in the body and function in both the peripheral and the central nervous systems. Dopaminergic signaling pathways are crucial to the maintenance of physiological processes and an unbalanced activity may lead to dysfunctions that are related to neurodegenerative diseases. Unveiling the neurobiology and the molecular mechanisms that underlie these illnesses may contribute to the development of new therapies that could promote a better quality of life for patients worldwide. In this review, we summarize the aspects of dopamine as a catecholaminergic neurotransmitter and discuss dopamine signaling pathways elicited through dopamine receptor activation in normal brain function. Furthermore, we describe the potential involvement of these signaling pathways in evoking the onset and progression of some diseases in the nervous system, such as Parkinson's, Schizophrenia, Huntington's, Attention Deficit and Hyperactivity Disorder, and Addiction. A brief description of new dopaminergic drugs recently approved and under development treatments for these ailments is also provided.

Entities:  

Keywords:  Central nervous system; Dopamine pathway; Neurodegenerative diseases; Neurotransmitter

Mesh:

Substances:

Year:  2018        PMID: 30446950     DOI: 10.1007/s10571-018-0632-3

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  441 in total

Review 1.  Presynaptic ionotropic receptors and the control of transmitter release.

Authors:  A B MacDermott; L W Role; S A Siegelbaum
Journal:  Annu Rev Neurosci       Date:  1999       Impact factor: 12.449

Review 2.  Cytotoxic and genotoxic potential of dopamine.

Authors:  A H Stokes; T G Hastings; K E Vrana
Journal:  J Neurosci Res       Date:  1999-03-15       Impact factor: 4.164

Review 3.  The glutamate receptor ion channels.

Authors:  R Dingledine; K Borges; D Bowie; S F Traynelis
Journal:  Pharmacol Rev       Date:  1999-03       Impact factor: 25.468

4.  The evoked heart rate response to periodic leg movements of sleep.

Authors:  J W Winkelman
Journal:  Sleep       Date:  1999-08-01       Impact factor: 5.849

Review 5.  Dopamine transporters and neuronal injury.

Authors:  G W Miller; R R Gainetdinov; A I Levey; M G Caron
Journal:  Trends Pharmacol Sci       Date:  1999-10       Impact factor: 14.819

6.  alpha2C adrenoceptors inhibit adenylyl cyclase in mouse striatum: potential activation by dopamine.

Authors:  W Zhang; V Klimek; J T Farley; M Y Zhu; G A Ordway
Journal:  J Pharmacol Exp Ther       Date:  1999-06       Impact factor: 4.030

7.  Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans.

Authors:  K J Werhahn; E Kunesch; S Noachtar; R Benecke; J Classen
Journal:  J Physiol       Date:  1999-06-01       Impact factor: 5.182

8.  G protein-mediated mitogen-activated protein kinase activation by two dopamine D2 receptors.

Authors:  E Y Choi; D Jeong; K W Park; J H Baik
Journal:  Biochem Biophys Res Commun       Date:  1999-03-05       Impact factor: 3.575

9.  Brain receptors for antipsychotic drugs and dopamine: direct binding assays.

Authors:  P Seeman; M Chau-Wong; J Tedesco; K Wong
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

10.  Dissociation in effects of lesions of the nucleus accumbens core and shell on appetitive pavlovian approach behavior and the potentiation of conditioned reinforcement and locomotor activity by D-amphetamine.

Authors:  J A Parkinson; M C Olmstead; L H Burns; T W Robbins; B J Everitt
Journal:  J Neurosci       Date:  1999-03-15       Impact factor: 6.167

View more
  102 in total

1.  Sex and strain differences in dynamic and static properties of the mesolimbic dopamine system.

Authors:  Maria Teresa Rivera-Garcia; Aqilah M McCane; Tara G Chowdhury; Kathryn G Wallin-Miller; Bita Moghaddam
Journal:  Neuropsychopharmacology       Date:  2020-07-14       Impact factor: 7.853

2.  Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D3 Dopamine Receptor Agonist.

Authors:  Amy E Moritz; R Benjamin Free; Warren S Weiner; Emmanuel O Akano; Disha Gandhi; Ara Abramyan; Thomas M Keck; Marc Ferrer; Xin Hu; Noel Southall; Joseph Steiner; Jeffrey Aubé; Lei Shi; Kevin J Frankowski; David R Sibley
Journal:  J Med Chem       Date:  2020-05-12       Impact factor: 7.446

3.  Effect of Chronic Methylphenidate Treatment in a Female Experimental Model of Parkinsonism.

Authors:  Hannah V Oakes; David McWethy; Shannon Ketchem; Lily Tran; Kaitlyn Phillips; Laura Oakley; Richard J Smeyne; Brooks B Pond
Journal:  Neurotox Res       Date:  2021-03-05       Impact factor: 3.911

Review 4.  Come Fly with Me: An overview of dopamine receptors in Drosophila melanogaster.

Authors:  Caline S Karam; Sandra K Jones; Jonathan A Javitch
Journal:  Basic Clin Pharmacol Toxicol       Date:  2019-07-09       Impact factor: 4.080

5.  Dopaminergic Receptors as Neuroimmune Mediators in Experimental Autoimmune Encephalomyelitis.

Authors:  E C D Gonçalves; V Lieberknecht; V V Horewicz; B D Rabelo; F A Felipetti; A L S Rodrigues; D F Martins; R C Dutra
Journal:  Mol Neurobiol       Date:  2021-08-25       Impact factor: 5.590

6.  Combining multilayered wrinkled polymer SERS substrates and spectral data processing for low concentration analyte detection.

Authors:  Benjamin Charron; Vincent Thibault; Jean-Francois Masson
Journal:  Anal Bioanal Chem       Date:  2022-06-01       Impact factor: 4.142

7.  Phenotypic profiling of mGlu7 knockout mice reveals new implications for neurodevelopmental disorders.

Authors:  Nicole M Fisher; Robert W Gould; Rocco G Gogliotti; Annalise J McDonald; Hana Badivuku; Susmita Chennareddy; Aditi B Buch; Annah M Moore; Matthew T Jenkins; W Hudson Robb; Craig W Lindsley; Carrie K Jones; P Jeffrey Conn; Colleen M Niswender
Journal:  Genes Brain Behav       Date:  2020-04-14       Impact factor: 3.449

8.  Synthesis and Pharmacological Evaluation of Noncatechol G Protein Biased and Unbiased Dopamine D1 Receptor Agonists.

Authors:  Pingyuan Wang; Daniel E Felsing; Haiying Chen; Sweta R Raval; John A Allen; Jia Zhou
Journal:  ACS Med Chem Lett       Date:  2019-04-05       Impact factor: 4.345

9.  Variable abnormality of the melanopsin-derived portion of the pupillary light reflex (PLR) in patients with Parkinson's disease (PD) and parkinsonism features.

Authors:  Bruce I Gaynes; Adnaan Zaffer; Raman Yousefzai; Mario Chazaro-Cortes; Kalea Colletta; Sandra L Kletzel; Mary Beth Jost; Youngsook Park; Jasvinder Chawla; Mark V Albert; Ting Xiao
Journal:  Neurol Sci       Date:  2021-05-04       Impact factor: 3.307

10.  Biogenic amine neurotransmitters promote eicosanoid production and protein homeostasis.

Authors:  Kishore K Joshi; Tarmie L Matlack; Stephanie Pyonteck; Mehul Vora; Ralph Menzel; Christopher Rongo
Journal:  EMBO Rep       Date:  2021-01-20       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.